EST
DXCM icon

EA Series Trust’s DexCom DXCM Stock Holding History

EA Series Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$337K Buy
+2,623
New +$317K 0.01% 924

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

EA Series Trust's DXCM Position: Q2 2023 in Review

EA Series Trust opened a new position in DexCom (DXCM) in Q2 2023: 2,623 shares worth $337K. The stake represents 0.01% of the portfolio and ranks #924 among its holdings.

954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • EA Series Trust held 2,623 shares of DexCom worth $337K as of Q2 2023.
  • DexCom was a new EA Series Trust position in Q2 2023.
  • DexCom made up 0.01% of EA Series Trust's portfolio in Q2 2023, its #924 holding.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.